What does it take to make it?
What does it take to make it for new biotech companies?
Wenche Gerhardsen is Head of Communications at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator. You can reach her at wg@oslocancercluster.no
What does it take to make it for new biotech companies?
Eli Lilly selected Norway as the site for its groundbreaking study project, despite the decline of the recent year’s number of clinical cancer trials.
World-leading translational cancer research entered Oslo Cancer Cluster Innovation Park last week and created a buzz.
The Cancer Mission Hub Norway arranged its yearly high-level meeting for the fourth time. This is what was discussed.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.